Implitapide

N/A

Report date: 2022/11/25 18:08:19
NME

Base Information

Drug NameImplitapide
Drug Alias NameImplitapida英普他匹Implitapidum英普他派AEGR 427 implitapide +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsHypertriglyceridemiaHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAegerion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedical Research Laboratories International Inc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHyperlipoproteinemia Type II

Other Information

ATC CodeN/A
Related LinksDrugBank